Checkout the latest news from $IMUN which includes updates on its equity stake in Cytocom, Phase 2 FDA trial on Cyto-201 and more. https://t.co/pZDBI1Hhmp  #IMUN #FDA #Cytocom #Cyto201 #COVID19 #stocks #investing https://t.co/AVD5F906qb